Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 10, 2025

Stocks Supported by Hopes the US Government Will Soon Reopen

View original at nasdaq.com
Stocks Supported by Hopes the US Government Will Soon Reopen The S&P 500 Index ($SPX) (SPY) today is up +1.10%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.55%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.81%…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Upgraded Eli Lilly to outperform from market perform with price target of $1,104

    80% confidence
  • Q3 profits have risen 14.6% thus far, more than doubling expectations of 7.2% y/y

    80% confidence
  • Expects substantial rebound in US economy in Q1 with limited room for further rate cuts

    80% confidence
  • 82% of S&P 500 companies that reported Q3 earnings beat forecasts, on course for best quarter since 2021

    80% confidence
  • Tariffs are an imposition of taxes on Americans, which is core power of Congress

    80% confidence
  • The effects of the tariffs have largely been confined to goods, with little spillover into services inflation or inflation expectations, which remain relatively well-anchored around our 2% target

    80% confidence
  • Downgraded Applied Optoelectronics to sell from neutral with price target of $15

    80% confidence
  • Upgraded Celestica to buy from neutral with price target of $375

    80% confidence
  • Raised price target on Albemarle to $85 from $70

    80% confidence
  • Labor market is softening and wage growth is moderating, without pressure on labor costs

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com